medigraphic.com
ISSN 0028-3851 (Print)

2021, Number 2

<< Back Next >>

Rev Neurol Neurocir Psiquiat 2021; 49 (2)

Unusual Guillain-Barré syndrome and cerebellar ataxia in a pediatric patient associated with COVID-19

Álvarez A, Alonso M, Ospino D, Escamilla V

Language: Spanish
References: 14
Page: 66-68
PDF size: 134.96 Kb.


ABSTRACT

Clinical case of unusual presentation is introduced, with evidence of cerebellar ataxia and Guillain-Barré syndrome of axonal type, in a pediatric patient, related to the appearance of SARS-CoV-2 infection. We also carry out a review of recent medical literature.


REFERENCES

  1. Bridwell R, Long B, Gottlieb M. Neurologic complications of COVID-19. Am J Emerg Med. 2020; 38 (7): 1549.e3-1549.e7.

  2. Scheidl E, Canseco DD, Hadji-Naumov A, Bereznai B. Guillain-Barré syndrome during SARS-CoV-2 pandemic: a case report and review of recent literature. J Peripher Nerv Syst. 2020; 25 (2): 204-207. doi: 10.1111/jns.12382.

  3. Gupta A, Paliwal VK, Garg RK. Is COVID-19-related Guillain-Barré syndrome different? Brain Behav Immun. 2020; 87: 177-178. doi: 10.1016/j.bbi.2020.05.051.

  4. van den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC, van Doorn PA. Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol. 2014; 10 (8): 469-482.

  5. Mannheim J, Gretsch S, Layden JE, Fricchione MJ. Characteristics of hospitalized pediatric coronavirus disease 2019 cases in Chicago, Illinois, March-April 2020. J Pediatric Infect Dis Soc. 2020; 9 (5): 519-522. doi: 10.1093/jpids/piaa070.

  6. Abu-Rumeileh S, Abdelhak A, Foschi M, Tumani H, Otto M. Guillain-Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases. J Neurol. 2020; 1-38. doi: 10.1007/s00415-020-10124-x.

  7. Christy A. COVID-19: a review for the pediatric neurologist. J Child Neurol. 2020; 35 (13): 934-939. doi: 10.1177/0883073820939387.

  8. Garg RK. Spectrum of neurological manifestations in COVID-19: a review. Neurol India. 2020; 68 (3): 560-572. doi: 10.4103/0028-3886.289000.

  9. Toscano G, Palmerini F, Ravaglia S, Ruiz L, Invernizzi P, Cuzzoni MG et al. Guillain-Barré syndrome associated with SARS-CoV-2. N Engl J Med. 2020; 382 (26): 2574-2576. doi: 10.1056/NEJMc2009191.

  10. Dimachkie MM, Barohn RJ. Guillain-Barré syndrome and variants. Neurol Clin. 2013; 31 (2): 491-510. doi: 10.1016/j.ncl.2013.01.005.

  11. Khalifa M, Zakaria F, Ragab Y, Saad A, Bamaga A, Emad Y et al. Guillain-Barré syndrome associated with severe acute respiratory syndrome coronavirus 2 detection and coronavirus disease 2019 in a child. J Pediatric Infect Dis Soc. 2020; 9 (4): 510-513. doi: 10.1093/jpids/piaa086.

  12. Frank CHM, Almeida TVR, Marques EA, de Sousa Monteiro Q, Feitoza PVS, Borba MGS et al. Guillain-Barré syndrome associated with SARS-CoV-2 infection in a pediatric patient. J Trop Pediatr. 2020; fmaa044. doi: 10.1093/tropej/fmaa044.

  13. Paybast S, Gorji R, Mavandadi S. Guillain-Barré syndrome as a neurological complication of novel COVID-19 infection: a case report and review of the literature. Neurologist. 2020; 25 (4): 101-103. doi: 10.1097/NRL.0000000000000291.

  14. Umapathi T. Does COVID-19 cause axonal GBS? J Clin Neurosci. 2020; 78: 448. doi: 10.1016/j.jocn.2020.05.057.




2020     |     www.medigraphic.com